Drug Search Results

TPX-100

Alternative Names: tpx-100, tpx100, tpx 100
Latest Update: 2019-11-09
Latest Update Note: News Article

Product Description

TPX-100 is a candidate first-in-class disease modifying osteoarthritis drug(DMOAD).

Mechanisms of Action: ITG Binder

Novel Mechanism: Yes

Modality: Peptide/Protein

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: OrthoTrophix
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for TPX-100

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Osteoarthritis, Knee

Trial	Phase	Trial Status	Disease	Primary Completion Date
TPX-100-4	N/A	Completed	Osteoarthritis, Knee	2017-10-01
TPX-100-2	P2	Completed	Osteoarthritis, Knee	2017-08-01
TPX-100	P2	Completed	Osteoarthritis, Knee	2016-09-01

Recent News Events

Date	Type	Title
11/09/2019	News Article	OrthoTrophix Presents Evidence for Disease Modification in Knee Osteoarthritis by TPX-100 at American College of Rheumatology Annual Meeting
06/28/2019	News Article	2019 Market Spotlight on Osteoarthritis & Osteoarthritis Pain - Pfizer Leads Industry Sponsors with the Highest Number of Clinical Trials for Osteoarthritis - ResearchAndMarkets.com
06/28/2019	News Article	Global Osteoarthritis & Osteoarthritis Pain Market 2019 - There Have Been 40 Licensing & Asset Acquisition Deals Involving Osteoarthritis Drugs During 2013-2018
06/12/2019	News Article	OrthoTrophix Presents Clinical Data at European Congress of Rheumatology

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions